Myeloproliferative Neoplasms Clinical Trials 201

April 2022

Clinical trials play a vital role in moving treatment and research advances forward. The Clinical Trials 201 program tackles common misconceptions and provides clear, actionable information about trials, sharing tools and resources for patients with essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF) who are considering clinical trial participation.

Program topics include:

Personalize Your Experience!

Create an account to save items and receive information curated just for you.
Create Account

[ACT]IVATED MPN program is brought to you by the Patient Empowerment Network. It is made possible through support from AbbVie, Inc. and generous donations from people like you.

Share On:

Facebook
Twitter
LinkedIn